Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-arm, Non-randomized, Open, Drug Tolerance Trial of Cinobufacini Injection Intraperitoneal Perfusion Treatment on Digestive System Cancer Patients With Ascites

NCT02530398 is registered in ClinicalTrials.gov with Dongfang Hospital Beijing University of Chinese Medicine as lead sponsor.

NCT NCT02530398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02530398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-arm, Non-randomized, Open, Drug Tolerance Trial of Cinobufacini Injection Intraperitoneal Perfusion Treatment on Digestive System Cancer Patients With Ascites
Lead sponsor
Dongfang Hospital Beijing University of Chinese Medicine
Phase
Phase 1
Overall status
Unknown status
Start date
July 31, 2015
Completion date
June 30, 2018
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

digestive system cancer, malignant ascites